|
Alzheimer's Disease Treatment and Illness Perceptions Survey (TIPS) II Clinical Trials Data presented on Clinical Trials Search is not meant to be a substitute for qualified medical advice, visits or professional assistance with a genuine dr.. We are not doctors. Always consult your mD about Alzheimer's Disease Treatment and Illness Perceptions Survey (TIPS) II conditions. Clinical Trials Search.org is a site devoted to listing clinical research studies in human subjects. Alzheimer's Disease Treatment and Illness Perceptions Survey (TIPS) II Clinical research trials and Alzheimer's Disease Treatment and Illness Perceptions Survey (TIPS) II medical trials take place in many of places throughout the U.S.A.. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials usually evaluate the effectiveness of new does drugs. The purpose of the studies / projects is to solve specific human healthcare questions. Clinical trials are a popular way for mDs, government agencies, and private sector companies to find cures for all varieties of conditions, like Alzheimer's Disease Treatment and Illness Perceptions Survey (TIPS) II. Alzheimer's Disease Treatment and Illness Perceptions Survey (TIPS) II Clinical Trials and other clinical trials allow for volunteers to have health treatment options before they are available to the masses. Many times the human subjects acquire professional assistance for free of charge, and sometimes they are compensated for their time. Occasionally there is a cost for a Alzheimer's Disease Treatment and Illness Perceptions Survey (TIPS) II clinical trial. Test subjects typically obtain the finest healthcare available for their Alzheimer's Disease Treatment and Illness Perceptions Survey (TIPS) II condition. Dangers are a reality, nevertheless, and might include additional or frequent doctor trips, medical dangers (possibly life-jeopardising), and/or the treatment being ineffectual. Trials are federally regulated with strict guidelines to protect clinical trials patients.
|
|
|
|
|
|
|
Home > "A" Clinical Trials Conditions > Alzheimer's Disease Treatment and Illness Perceptions Survey (TIPS) II  Alzheimer's Disease Treatment and Illness Perceptions Survey (TIPS) II
Alzheimer's Disease Treatment and Illness Perceptions Survey (TIPS) II
For Condition: Alzheimer Disease
Status: Recruiting
Sponsor(s): Alzheimer's Association ,
Synopsis: The TIPS Study, or Treatment and Illness Perceptions Survey, is a study funded by the national Alzheimer's Association to learn more about differences between African Americans' and Whites' attitudes, beliefs, and experiences related to Alzheimer's disease (AD). The study involves a one-time 30-minute telephone survey in which participants are asked about a range of topics related to AD, including their personal experiences, their beliefs about the disease's symptoms and risk factors, and their attitude toward possible future treatment options. Information from the survey will be used to develop more culturally sensitive health education and healthcare services for persons with AD.
Details: The main goal of the Boston University's TIPS II project is to examine differences in Alzheimer's disease (AD) illness perceptions between African Americans and Whites in order to better understand attitudes and beliefs and to develop more culturally sensitive health services for AD. This 30-minute telephone survey will include a total of 140 first-degree relatives and caregivers of people with AD, as well as a comparison group of 70 adults without family history. The researchers will assess 1) beliefs about AD; 2) the perceived threat it poses; 3) sources of information about AD; 4) knowledge of basic facts about AD; 5) appraisal of AD treatments; and 6) intentions regarding current and emerging care options. Based on preliminary data, this study hypothesize that, as compared to Whites, African Americans will report lower levels of perceived threat, fewer sources of information, less awareness of facts, and less interest in care options. Focus group interviews with African American participants will help interpret study findings and inform recommendations for health education interventions. Findings will inform the development of a set of recommendations for AD health educators that will help them tailor their interventions to African Americans. Such educational programs promote increased use of assessment, treatment, and caregiver assistance services. Results will also be used as pilot data in a proposal for a national survey of caregivers and relatives. This program of research will address a growing need for increased understanding of beliefs, knowledge, and intentions regarding AD. A total of 210 participants are being sought (105 African Americans, and 105 Whites). Participants who complete the survey will be given a $10.00 check, plus informational brochures on AD and the latest newsletter from the Boston University Alzheimer's Disease Center.
Eligibility:
Study Type: Observational, Psychosocial, Cross-Sectional, Defined Population, Prospective Study
Minimum Age/Maximum Age: /
Genders: Both
Protocol Entry Criteria: Inclusion Criteria: Three groups of participants are sought to take part in the survey: - 70 primary caregivers(current or former) of persons with AD, or related memory disorders - 70 adult children and siblings of people with AD or related memory disorders - 70 adults age 40 and older without immediate family history of AD or related memory disorders Exclusion Criteria: - Not fluent in English - Cognitive impairment that would preclude responding to a 30-minute telephone survey
Total Enrollment: 210
Location and Contact Information:
Overall Study Official:
ScottRoberts, Study Director, Boston University Alzheimer's Disease Center
Boston University School of Medicine, Alzheimer's Disease Center *Recruiting*
Boston, Massachusetts, 02118
United States
Recruiting Dapo Akinleye 617-638-6143
Additional Information:
Study ID Numbers: IA0045; BUMC 2002-308,NIRG-02-3712
Study Start Date: January 2003
Record last reviewed: May 2004
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00059410
Other Alzheimer Disease Studies:
1. The Safety and Efficacy of an Investigational Drug in Delaying the Progression of Alzheimer's Disease
2. Bathing persons with Alzheimer's disease aT Home (The BATH Study)
3. Treatment of Behavioral Symptoms in Alzheimer's Disease
4. Multicenter Trial of Prednisone in Alzheimer's Disease
5. Evaluation of Age- and Alzheimer's Disease-Related Memory Disorder
Related Studies:
Other Alzheimer Disease Clinical Trials
Other Massachusetts Clinical Trials
Other Boston Clinical Trials
Alzheimer's Disease Treatment and Illness Perceptions Survey (TIPS) II
|
|
|
|
|
|
|
|
